FlexPro MD (Krill oil, Astaxanthin, Hyaluronic acid)

FlexPro MD combines krill oil, astaxanthin, and hyaluronic acid to reduce joint inflammation through NF-κB pathway inhibition. Clinical trials show it decreases knee osteoarthritis pain and improves mobility while suppressing inflammatory markers IL-6 and TNF-α.

Origin & History

FlexPro MD is a branded dietary supplement combining krill oil from Antarctic krill (Euphausia superba), astaxanthin from Haematococcus pluvialis microalgae, and sodium hyaluronate produced via fermentation by Streptococcus zooepidemicus. The formulation typically contains 70% krill oil extracted using ethanol-hexane or subcritical solvents, 7% H. pluvialis extract, and 7% sodium hyaluronate.

Historical & Cultural Context

No historical or traditional medicine use was reported for FlexPro MD as a branded combination. Individual components like krill oil, astaxanthin from H. pluvialis, and hyaluronic acid are modern isolates without documented use in ancient traditional medicine systems.

Health Benefits

• Reduces joint pain and improves mobility in knee osteoarthritis (human clinical trial evidence) • Decreases inflammatory cytokines including IL-6 and TNF-α via NF-κB inhibition (preclinical mouse studies) • Suppresses inflammatory enzymes iNOS and COX-2 in a dose-dependent manner (in vitro cell studies at 10-100 μg/mL) • Provides phospholipid-bound omega-3 fatty acids (EPA/DHA) with enhanced bioavailability versus triglyceride forms • Delivers antioxidant protection through astaxanthin, suppressing oxidative DNA damage (mechanistic evidence)

How It Works

FlexPro MD's omega-3 fatty acids EPA and DHA from krill oil inhibit the NF-κB inflammatory pathway, reducing production of pro-inflammatory cytokines IL-6 and TNF-α. Astaxanthin provides additional anti-inflammatory effects by suppressing inflammatory enzymes iNOS and COX-2 in a dose-dependent manner. Hyaluronic acid supports joint lubrication and cartilage matrix integrity through direct synovial fluid supplementation.

Scientific Research

A multicenter, randomized, double-blind, placebo-controlled trial demonstrated FlexPro MD reduced pain and improved mobility in humans with knee osteoarthritis, though specific sample size and PMID details were not provided in available data. Preclinical studies in LPS-induced arthritis mice showed reduced inflammatory cytokines via NF-κB inhibition, with in vitro RAW264.7 cell studies confirming dose-dependent suppression of inflammatory markers.

Clinical Summary

Human clinical trials demonstrate FlexPro MD's efficacy in reducing joint pain and improving mobility in patients with knee osteoarthritis, though specific sample sizes and duration require further documentation. Preclinical mouse studies show significant decreases in inflammatory cytokines IL-6 and TNF-α through NF-κB pathway inhibition. In vitro cell studies confirm dose-dependent suppression of inflammatory enzymes iNOS and COX-2. The evidence is primarily based on combination formula studies rather than individual component research.

Nutritional Profile

FlexPro MD is a multi-ingredient joint health supplement combining three bioactive components. **Krill Oil** provides phospholipid-bound omega-3 fatty acids, typically delivering EPA (~60-75 mg) and DHA (~35-45 mg) per serving in a more bioavailable phosphatidylcholine-conjugated form compared to standard fish oil triglycerides (estimated 30-60% higher absorption). Krill oil also contains choline (~20-35 mg per typical serving) as phosphatidylcholine, contributing to cell membrane integrity. **Astaxanthin**, a xanthophyll carotenoid naturally present in krill (typically 1-4 mg per serving, depending on formulation), acts as a potent lipid-soluble antioxidant with an oxygen radical absorbance capacity (ORAC) significantly exceeding beta-carotene and vitamin E; its bioavailability is enhanced when co-administered with the lipid matrix of krill oil (fat-soluble absorption improved ~2-3× with dietary fat). **Hyaluronic Acid (HA)**, a glycosaminoglycan (typically 40-80 mg per serving of high-molecular-weight HA, ~1,000-1,800 kDa), supports synovial fluid viscosity and cartilage hydration; oral bioavailability of intact HA is relatively low (~1-5%), though degraded fragments are absorbed in the gut and redistributed to joint tissues as demonstrated in radiolabeled tracer studies. The formulation is low in macronutrients (negligible protein, carbohydrate; ~1-2 g total fat from krill oil per serving). No significant vitamin or mineral content beyond trace amounts of vitamin A (~50-100 IU from krill) and vitamin E (sometimes added as a stabilizer, ~1-2 IU). The synergistic lipid matrix of krill oil likely enhances astaxanthin and potentially HA fragment absorption. The phospholipid fraction also provides small amounts of sphingomyelin. No fiber or significant caloric contribution (~10-20 kcal per serving). Bioactive compounds work through complementary mechanisms: omega-3s and astaxanthin target NF-κB-mediated inflammatory pathways (suppressing COX-2, iNOS, IL-6, TNF-α), while HA provides structural and lubricating support to articular cartilage and synovial fluid.

Preparation & Dosage

Clinically studied doses contain 321 mg krill oil, 30 mg hyaluronic acid, and 2 mg astaxanthin per dose (total ~462 mg with excipients). The formulation is standardized to Superba® krill oil, Zanthin® astaxanthin (2 mg from 25-35 mg H. pluvialis extract), and Flexonic® sodium hyaluronate (33 mg). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Glucosamine sulfate, chondroitin sulfate, MSM, curcumin, boswellia serrata

Safety & Interactions

FlexPro MD is generally well-tolerated with minimal reported side effects in clinical studies. Krill oil may increase bleeding risk when combined with anticoagulant medications like warfarin due to omega-3 content. Individuals with shellfish allergies should exercise caution as krill is a crustacean-derived ingredient. Safety during pregnancy and lactation has not been established, so consultation with healthcare providers is recommended before use.